King Pharmaceuticals, the manufacturer of INTAL® Inhaler (cromolyn sodium inhalation aerosol) has announced that it will discontinue production of the inhaler. Currently, orders for INTAL inhalers will be accepted until the manufacturer’s supply is sold out, so the exact date of unavailability isn’t known.
A statement from the company explains: “This decision is based upon many factors, including our inability to identify a qualified manufacturer for chlorofluorocarbon (CFC) propellant inhalers and our inability, despite best efforts, to reformulate INTAL® to a chlorofluorocarbon-free or hydrofluoroalkane (HFA) propellant formulation.”
Because of the planned phase-out, the manufacturer suggests that doctors refrain from initiating treatment with this product. INTAL will remain available through pharmacies and wholesalers until the current supply runs out.
Anyone with questions or concerns can contact the company’s Professional Information Services Department at (800) 776-3637.
Related posts:
- Maximize the Mist – Keep Inhalers Clean, Primed and Ready
- Mastering HFA Inhalers – Step-by-Step Instructions
- Internet Warning for Patients Who Use Metered Dose Inhalers
RSS Feed